ARGOS THERAPEUTICS INC 4
4 · ARGOS THERAPEUTICS INC · Filed Jun 19, 2015
Insider Transaction Report
Form 4
Nicolette Charles A.
CSO and Vice President of R&D
Transactions
- Award
Stock Option (right to buy)
[F1]2015-06-17+75,000→ 75,000 totalExercise: $7.80Exp: 2025-06-16→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 17, 2015 and vests as to 25% of the shares underlying this option on June 17, 2016, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning June 17, 2016.
Signature
Lori R. Harrelson, as attorney-in-fact|2015-06-19